Logo

BD s Allegedly Illegal Iraqi Shipments, FDA Rule Violations Tops Most-Read GenomeWeb News Stories Last Week

Dec 05, 2005

NEW YORK, Dec. 5 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 2.

 

1. BD Attempted Illegal Shipments to Iraq and Violated FDA Rules, Wrongful Termination Suit Alleges (from Dec. 1)

2. US Department of Homeland Security Awards US Genomics $16.2M (from Nov. 30)

3. LabCorp to Sell Roche's AmpliChip CYP450 Assay (from Nov. 28)

4. Agilent Buys Molecular Imaging in Bid to Expand Nanotech Imaging Business (from Nov. 29)

5. Invitrogen Wins One Patent Battle Against Clontech on Appeal; Status of Two Remaining Patents Unclear (from Dec. 1)

Breaking News
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.